Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 84 PS1-05-44 | DOI: 10.1530/endoabs.84.PS1-05-44

ETA2022 Poster Presentations Miscellaneous (10 abstracts)

The effect of testosterone supplementation on the hpt axis in euthyroid hypogonadal adult men: a prospective observational study

Karel David 1 , Leen Antonio 2 , Frank Claessens 3 , Dirk Vanderschueren 2 & Brigitte Decallonne 2


1Ku Leuven, University Hospitals Leuven, Clinical and Experimental Endocrinology - Department of Chronic Diseases and Metabolism, Leuven, Belgium; 2Ku Leuven, University Hospitals Leuven, Endocrinology, Leuven, Belgium; 3Ku Leuven, Molecular and Cellular Endocrinology, Leuven, Belgium


Background and Objective: It is known that androgens decrease and estrogens increase TBG. In female to male transsexuals under testosterone replacement, decrease of TBG has been shown, but also an increased T3/T4 ratio despite stable free T4 and TSH, suggesting increased conversion to T3 by testosterone. We wanted to study the HPT axis in hypogonadal cis-males before and after testosterone replacement.

Method: Prospective observational study in adult male patients with hypogonadism in the setting of an outpatient endocrine clinic. Serum samples were taken prior to (visit 1) and at the first consultation (visit 2) under testosterone replacement. Males with history of thyroid disorder, having abnormal thyroid function at visit 1, treated with betaHCG, or taking drugs at baseline or during follow-up knowing to affect thyroid function were excluded. Paired t-test or Wilcoxon matched-pairs signed rank test was applied where appropriate.

Results: A cohort of n = 24 hypogonadal male patients was studied. Mean age was 52.9+/- 15.4 years, n = 17 patients were treated for structural hypogonadism (n = 8 hypogonadotropic, n = 9 hypergonadotropic), n = 7 patients were treated for functional hypogonadism. Median time between visit 1 and 2 was 2.53 months [range 1.15-11.5]. As expected, total and free testosterone increased significantly (see Table). TSH was not different, but T4 (total and free) decreased. Total T3 was not different, and T3/T4 ratio increased between visit 1 and 2.

Visit 1Visit 2np value
Testosterone (ng/dL)249.1 [15.1-649.1]368.3 [122.9-1297]240.0003
Free testosterone (ng/dL)3.95 [0.20-7.30]6.45 [2.20-16.90]24<0.0001
TSH (mIU/l)1.54 +/-0.851.46 +/-0.74240.6490
Total T4 (µg/dL)7.45 [4.70-12.40]6.90 [4.50-11.30]240.0294
Free T4 (ng/dL)1.32 +/-0.161.24 +/-0.19180.0337
Total T3 (ng/dL)117.5 +/-30.4123.2 +/-24.5240.1010
T3/T4 ratio (x103)15.35 [8.94-22.34]16.15 [11.56-27.71]240.0101

Conclusion: In euthyroid hypogonadal cis-males, testosterone replacement did not alter TSH, decreased total T4 and free T4, but not total T3. The increased T3/T4 ratio suggests increased conversion and/or or differential binding to TBG.

Volume 84

44th Annual Meeting of the European Thyroid Association (ETA) 2022

Brussels, Belgium
10 Sep 2022 - 13 Sep 2022

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.